Friday, July 31, 2026

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

North Korea’s New Housing Project: 2,500 Units for Fallen Soldiers’ Families in Pyongyang

North Korea builds a 2,500-unit housing complex for families of troops deployed to Russia, amid concerns of underreported military casualties.

Understanding Iron Deficiency Anemia: Symptoms, Risks, and Prevention Tips

Anemia, especially iron deficiency, can lead to fatigue and serious health issues. Early diagnosis and treatment are crucial.

Tag: market

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

HLB PEP Achieves FDA Registration for Vasopressin API: What This Means for Global Markets

HLB PEP has registered Vasopressin API with the FDA, aiming for global market entry and expanding its peptide portfolio.

Samsung Biologics’ Q2 Success: 30% Revenue Growth and Global Expansion Plans

Samsung Biologics exceeded Q2 market expectations due to stable performance from existing plants and new facilities in the U.S.

Kia Sportage Triumphs: 2026’s Top Compact SUV in Europe – What Makes It Stand Out?

Kia's Sportage excels in a German SUV comparison, topping evaluations in multiple categories and showcasing strong sales in Europe.

Samsung Galaxy Card: Unlock 200 USD Bonus Rewards with New Credit Card Launch in the U.S.

Samsung introduces the Galaxy Card in the U.S., offering cashback rewards and discounts, enhancing user experience through Samsung Wallet integration.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

How Celltrion’s Omlyclo Achieved 16% Market Share in Europe: A Game-Changer for Biologics

Celltrion's biosimilars gain market share in Europe, with Omlyclo leading in Spain and Vegzelma maintaining strong presence amid competition.

Samsung’s AI PC Chip Gaia: What to Expect from 2027’s Cutting-Edge Technology?

Samsung Electronics is developing AI chips for PCs, aiming for mass production next year, marking its return to the PC chip market.

How Rebelion’s ATOM NPU and FuriosaAI’s RNGD Chip Are Revolutionizing AI Infrastructure in Europe

Korean AI startups Rebellions and FuriosaAI unveil strategies at RAISE Summit 2026, targeting European market with innovative technologies.

Bevacizumab Breakthrough: How Celltrion’s Vegzelma Secured Coverage in Major U.S. PBMs

Celltrion's Vegzelma gains preferred status with major U.S. PBMs, enhancing prescription access and boosting market share.

Daewoong Pharma Signs $1.45 Billion MENA Export Deal for ‘Enavogliflozin,’ Marking Record Global Sales

Daewoong Pharmaceutical's diabetes drug Enblo secures a $1.45 billion deal to enter MENA markets, marking a significant milestone.

LG Electronics Launches New Robotics Business Center: What This Means for the Future of AI and Automation in 2026

LG Electronics is launching a Robotics Business Center to enhance its robotics sector, focusing on AI-driven solutions and integrated operations.

LG StandByMe 2 Max: The Ultimate 32-Inch 4K Portable Screen Launching Globally

LG Electronics launches the 32-inch LG StandbyME 2 Max globally, enhancing mobility and viewing experience with 4K resolution.

Unlocking Cybersecurity: How China’s GLM-5.2 is Outperforming Top U.S. AI Models

Chinese AI firms are rapidly developing security-focused models like GLM-5.2 to compete with U.S. export restrictions on advanced AI.

LSCUS vs. Traditional Cable Companies: Who Dominates the AI Data Center Infrastructure?

LSCUS secures major AI data center contracts, enhancing its market position with significant revenue growth and innovative busduct technology.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.